For the Smithsonian National Zoo and Conservation Biology Institute (NZCBI), Christmas came early in 2025. Zookeepers were ...

Preparing for the CBSE Class 10 Science Pre-Board Exam 2026? Multiple Choice Questions (MCQs) form a crucial part of the ...

With the Class 12 board examinations approaching, the CBSE Biology sample paper offers students a clear guide to the exam ...

The CBSE Class 12 Biology exam will be held on March 27, 2026. It is normal to feel excited or a little nervous. Biology is ...

JERUSALEM, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides and proteins replacement therapies, today ...

Novel PTH analog achieves sustained calcium elevation for >3 days from single oral tablet, supporting development path toward once-daily alternative to daily injections JERUSALEM, Dec. 22, 2025 (GLOBE ...

First CTA authorization marks nChroma’s transition to a clinical-stage company; first patient dosing in Phase 1/2 trial planned for early 2026 Preclinical studies demonstrated CRMA-1001 delivers ...

Dec 15 (Reuters) - Private biotech company Dren Bio has entered into a strategic collaboration with French drugmaker Sanofi (SASY.PA), opens new tab to develop therapies for autoimmune diseases in a ...

TAIPEI, Taiwan — Taiwan's government proposed on Thursday to expand assisted reproduction access to single women and married same-sex female couples, as the democratic island faces a shrinking, aging ...

Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HIT It is the first and only potent, highly selective inhibitor of human 12-LOX in clinical ...

GRI Bio, Inc. (NASDAQ: GRI) on Wednesday shared topline data from the Phase 2a GRI-0621-IPF-02 trial evaluating GRI-0621 for idiopathic pulmonary fibrosis. IPF is a chronic, progressive lung disease ...

Tulane Ventures has invested $125,000 in Beken Bio, a biotechnology startup developing early-detection blood tests for aggressive cancers, bringing the company’s founder back to New Orleans as it ...